Draft:Deutivacaftor

Cystic fibrosis treatment drug From Wikipedia, the free encyclopedia

Deutivacaftor is a deuterated analogue of the cystic fibrosis drug ivacaftor. It is sold only as part of the combination product vanzacaftor/tezacaftor/deutivacaftor, sold under the brand name Alyftrek. It acts as a CFTR potentiator.[1]

CAS Number
Quick facts Clinical data, Routes ofadministration ...
Deutivacaftor
Clinical data
Routes of
administration
By mouth
Identifiers
  • N-(2,4-Di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
Chemical and physical data
FormulaC24H28N2O3
Molar mass392.499 g·mol−1
3D model (JSmol)
  • [2H]C([2H])([2H])C(c1cc(C(C)(C)C)c(NC(=O)c2c[nH]c3ccccc3c2=O)cc1O)(C([2H])([2H])[2H])C([2H])([2H])[2H]
  • InChI=1S/C24H28N2O3/c1-23(2,3)16-11-17(24(4,5)6)20(27)12-19(16)26-22(29)15-13-25-18-10-8-7-9-14(18)21(15)28/h7-13,27H,1-6H3,(H,25,28)(H,26,29)/i4D3,5D3,6D3 checkY[chembl]
  • Key:PURKAOJPTOLRMP-ASMGOKTBSA-N checkY[chembl]
Close

References

Related Articles

Wikiwand AI